Indonesia
· Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 21.14 trillion. The enterprise value is 25.33 trillion.
| Market Cap | 21.14T |
| Enterprise Value | 25.33T |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
IDX:HEAL has 14.89 billion shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 14.89B |
| Shares Outstanding | 14.89B |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 39.89% |
| Owned by Institutions (%) | 7.96% |
| Float | 7.84B |
Valuation Ratios
The trailing PE ratio is 45.36 and the forward PE ratio is 35.58. IDX:HEAL's PEG ratio is 2.51.
| PE Ratio | 45.36 |
| Forward PE | 35.58 |
| PS Ratio | 3.15 |
| PB Ratio | 3.51 |
| P/TBV Ratio | 4.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20.46 |
| PEG Ratio | 2.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.60, with an EV/FCF ratio of -23.38.
| EV / Earnings | 53.93 |
| EV / Sales | 3.78 |
| EV / EBITDA | 14.60 |
| EV / EBIT | 25.56 |
| EV / FCF | -23.38 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.11 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | -3.08 |
| Interest Coverage | 5.04 |
Financial Efficiency
Return on equity (ROE) is 10.48% and return on invested capital (ROIC) is 7.24%.
| Return on Equity (ROE) | 10.48% |
| Return on Assets (ROA) | 6.18% |
| Return on Invested Capital (ROIC) | 7.24% |
| Return on Capital Employed (ROCE) | 11.02% |
| Revenue Per Employee | 367.06M |
| Profits Per Employee | 25.72M |
| Employee Count | 17,626 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 35.80 |
Taxes
In the past 12 months, IDX:HEAL has paid 211.10 billion in taxes.
| Income Tax | 211.10B |
| Effective Tax Rate | 25.84% |
Stock Price Statistics
The stock price has increased by +4.41% in the last 52 weeks. The beta is 0.20, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +4.41% |
| 50-Day Moving Average | 1,271.00 |
| 200-Day Moving Average | 1,375.58 |
| Relative Strength Index (RSI) | 56.83 |
| Average Volume (20 Days) | 15,031,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 6.70 trillion and earned 469.73 billion in profits. Earnings per share was 31.31.
| Revenue | 6.70T |
| Gross Profit | 2.20T |
| Operating Income | 991.00B |
| Pretax Income | 816.92B |
| Net Income | 469.73B |
| EBITDA | 1.73T |
| EBIT | 991.00B |
| Earnings Per Share (EPS) | 31.31 |
Balance Sheet
The company has 580.11 billion in cash and 3.33 trillion in debt, giving a net cash position of -2,751.90 billion or -184.82 per share.
| Cash & Cash Equivalents | 580.11B |
| Total Debt | 3.33T |
| Net Cash | -2,751.90B |
| Net Cash Per Share | -184.82 |
| Equity (Book Value) | 6.02T |
| Book Value Per Share | 307.54 |
| Working Capital | 199.11B |
Cash Flow
In the last 12 months, operating cash flow was 1.03 trillion and capital expenditures -2,116.60 billion, giving a free cash flow of -1,083.36 billion.
| Operating Cash Flow | 1.03T |
| Capital Expenditures | -2,116.60B |
| Free Cash Flow | -1,083.36B |
| FCF Per Share | -72.76 |
Margins
Gross margin is 32.87%, with operating and profit margins of 14.78% and 7.01%.
| Gross Margin | 32.87% |
| Operating Margin | 14.78% |
| Pretax Margin | 12.19% |
| Profit Margin | 7.01% |
| EBITDA Margin | 25.80% |
| EBIT Margin | 14.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 0.74%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 0.74% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 26.94% |
| Buyback Yield | -1.53% |
| Shareholder Yield | -0.79% |
| Earnings Yield | 2.22% |
| FCF Yield | -5.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
IDX:HEAL has an Altman Z-Score of 3.87 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 4 |